ImetelChat

Given our CEO is shrewd and a risk taker and heavily vested in making the best / right steps in bringing Imetelstat to market in the greatest way possible, I think we can rest assured that there is a lot of “out of the box” thinking going on right now. These discussions certainly include funding, pa...

Yes, patience is hard in this space and time, as well as elsewhere for some of us, myself included. And I don’t mean to be overly philosophical with these posts and realize with so many people, patients and investors alike, struggling with their interest and participation in Geron / Imetelstat has b...

Thanks bucbeard for your kind response as always. I certainly would feel much more at home on the bluffs in hunting gear than in a lounge chair on Turtle Island but who knows what the impending may bring. And either would be a welcome venue for meeting up with you somewhere in the future. And thanks...

Part 3 of 3: Now we should all come back to face our confirmation biases, especially where our fortunes are at stake. I think a significant part of our CB flows from our nature versus the data, results or ideas presented. However, in regards to our Geron investments, I believe most of us will ultima...

Part 2 of 3: But then there is the science and what Geron is doing with it. I would differ strongly that most Geronites have not studied the science or competition at length and have assessed the possibilities. Certainly, none of us forget the dialogue about the disease modifying ability of Imetelst...

Part 1 of 3: I apologize at the outset of this post(s) as I know from what is on my mind and notes that it will be long and quite likely boring to many. If you turn back here I wouldn’t blame you, as my attempts at trying to basically keep myself grounded in thought and possibilities of the Geron sc...

rccola335, again, I am not an expert on any of this but I have listened to that podcast at least two or three times and I have always felt that the KOL’s speaking were holding back on their enthusiasm with Imetelstat partly maybe largely because of their (at least Dr Steensma) relationships with oth...

Thank you, I'm always grateful for another Thanksgiving Day (minus the overage on calories) and many other blessings including having ImetelChat. And likewise, I hope the holiday was a good one for you and all ImetelChat members and readers! I guess I thought it was more challenging than just taking...

Thanks for sharing this info, it certainly makes one think about what is going on with wanting to restate a previous poster. I realize our perspectives differ based on many aspects and I always defer to your experience and knowledge on the science, but I believe much can be explained based on where ...

Thanks to Bucbeard and Secret Third Arm for chiming in here on this slant of thinking. I am traveling some and spending a lot of time in and around the bluffs (i.e. hunting) right now so apologize for the slow response. I should also point out that the reference to COB in my initial comments should ...

I haven’t had much to say over the last several months because progress is apparent to me and continues to be articulated well by those intellectuals and medically vested among us. I have a little time here so decided to needlessly ramble on regarding the naysayers propensity to continually slander ...

Copied from YMB per biopearl's vacation post reference. stiglg6's post from 8/16/2019 an animal on this board suggested that there are no similairties worth mentioning between Geron and PCYC. How could this animal say such a thing? Is he or she ignorant to the similarities between Geron's imetelstat...

Geron Appoints Vice President, Human Resources MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior leadership to further strengthen th...

Sure, glad I could help hopefully w/o getting in your way. We all know you are busy and appreciate all your contributions!

For completeness, here are the links to the Geron 6/17/19 press release and the IMBark poster presentation. Note that the poster presentation link from my initial posts may be more usable as the various sections will enlarge when clicked on. http://ir.geron.com/news-releases/news-release-details/ger...

For completeness, here are the links to the Geron 6/17/19 press release and the slide presentation used by Dr. Fenaux. http://ir.geron.com/news-releases/news-release-details/geron-reports-two-imetelstat-data-presentations-european https://www.geron.com/file.cfm/53/docs/Imetelstat_IMerge%20Part%201_E...

karagozoglu12345, I wanted to comment on a couple of your earlier thoughts above. I might be wrong but I think some (not all) of your major concerns are built around “opinions” about what was causal to the stock price debacle and less related to Imetelstat’s science, CT and pre-CT results or what Ge...

FAVORABLE OVERALL SURVIVAL OF IMETELSTAT-TREATED RELAPSED/REFRACTORY MYELOFIBROSIS PATIENTS COMPARED WITH CLOSELY MATCHED REAL WORLD DATA https://library.ehaweb.org/eha/2019/24th/267073/andrew.kuykendall.favorable.overall.survival.of.imetelstat-treated.relapsed.html?f=listing%3D0%2Abrowseby%3D8%2Aso...

From GernOneShotLeftonGoal's post on Secret Third Arm blog on SA. Please refer to his post for his related comments. https://www.youtube.com/watch?v=OK6LWklTvd8 https://www.onclive.com/conference-coverage/eha-2019/imetelstat-provides-durable-transfusion-independence-in-lowerrisk-relapsed-refractory-...

Info provided by Fan on the YMB.